Paper36557635
Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases.
Effendi RMRA and 7 others. Microorganisms, 2022. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases. Papers, record 36557635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36557635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30765132 | Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. | Allergol Immunopathol (Madr) | 2019 | https://conductscience.org/library/papers/30765132 | PubMed |
| 2 | 35625774 | Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625774 | PubMed |
| 3 | 33828220 | Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon. | Sci Rep | 2021 | https://conductscience.org/library/papers/33828220 | PubMed |
| 4 | 26875998 | Akkermansia muciniphila and its role in regulating host functions. | Microb Pathog | 2017 | https://conductscience.org/library/papers/26875998 | PubMed |
| 5 | 27996081 | Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus. | J Cell Physiol | 2017 | https://conductscience.org/library/papers/27996081 | PubMed |
| 6 | 15388697 | Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. | Int J Syst Evol Microbiol | 2004 | https://conductscience.org/library/papers/15388697 | PubMed |
| 7 | 27502297 | β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/27502297 | PubMed |
| 8 | 35613313 | Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. | Gut Microbes | 2022 | https://conductscience.org/library/papers/35613313 | PubMed |
| 9 | 21904534 | Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. | Front Microbiol | 2011 | https://conductscience.org/library/papers/21904534 | PubMed |
| 10 | 24414342 | Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. | Clin Exp Med | 2015 | https://conductscience.org/library/papers/24414342 | PubMed |
| 11 | 26431583 | Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. | J Allergy Clin Immunol | 2016 | https://conductscience.org/library/papers/26431583 | PubMed |
| 12 | 29018410 | Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. | Front Microbiol | 2017 | https://conductscience.org/library/papers/29018410 | PubMed |
| 13 | 31337439 | Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31337439 | PubMed |
| 14 | 32049008 | Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. | Cell Rep | 2020 | https://conductscience.org/library/papers/32049008 | PubMed |
| 15 | 29221664 | Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29221664 | PubMed |
| 16 | 23319119 | The interplay between fiber and the intestinal microbiome in the inflammatory response. | Adv Nutr | 2013 | https://conductscience.org/library/papers/23319119 | PubMed |
| 17 | 27267710 | Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. | HIV Clin Trials | 2016 | https://conductscience.org/library/papers/27267710 | PubMed |
| 18 | 22672413 | Unbalance of intestinal microbiota in atopic children. | BMC Microbiol | 2012 | https://conductscience.org/library/papers/22672413 | PubMed |
| 19 | 27477587 | Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population. | Sci Rep | 2016 | https://conductscience.org/library/papers/27477587 | PubMed |
| 20 | 23831042 | Faecalibacterium prausnitzii and human intestinal health. | Curr Opin Microbiol | 2013 | https://conductscience.org/library/papers/23831042 | PubMed |
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955547 | Exploring Gut Microbial Metabolic Signatures Associated with the Gut-Lung Axis in Lung Adenocarcinoma. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/42955547 | PubMed |
| 42884728 | Nutrition, Circadian Regulation, and the Gut-Melatonin-Visceral Adipose Tissue Axis: An Integrative Narrative Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42884728 | PubMed |
| 42828644 | Next-generation probiotics and microbiome-based therapeutics highlighting Akkermansia muciniphila and Amuc_1100. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42828644 | PubMed |
| 42784285 | Aflatoxin B1, Gut Microbiota Dysbiosis, and the Intestinal Barrier: Implications for the Gut-Liver Axis and Extrahepatic Cancer Risk. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42784285 | PubMed |
| 42677167 | Gut microbiota-targeted bioactive peptides as emerging axis in nutritional therapeutics: trends, challenges, and prospects. | Front Nutr | 2026 | https://conductscience.org/library/papers/42677167 | PubMed |
| 42625911 | From genes to environment: A life-course approach to prevent pediatric autoimmune diseases. | World J Clin Pediatr | 2026 | https://conductscience.org/library/papers/42625911 | PubMed |
| 42597739 | Mental health and gut-brain crosstalk: implications for depression and Alzheimer's disease. | Neurosci Appl | 2026 | https://conductscience.org/library/papers/42597739 | PubMed |
| 42589357 | Enhanced Oral Delivery of Turmeric Extract via Spray-Dried Microparticles: Biopharmaceutical Performance and In Vitro Microbiota Modulation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589357 | PubMed |
| 42588100 | Gut Microbiota-Targeted Nutrition for Healthy Aging: Mechanistic Roles of Polyphenols and Dietary Fiber in Geroscience. | Nutrients | 2026 | https://conductscience.org/library/papers/42588100 | PubMed |
| 42516970 | Gut microbiota profiles in pediatric atopic dermatitis and their relationship with skin microbiota: an Indonesian case-control study. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42516970 | PubMed |
| 42511589 | Molecular Mechanisms of Gut Microbiota-Immune System Crosstalk: From Mucosal Architecture to Adaptive Immunity Programming. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511589 | PubMed |
| 42496153 | Faecalibacterium duncaniae-derived metabolites protect intestinal epithelial integrity under inflammatory conditions in dairy calves. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/42496153 | PubMed |
| 42436552 | Enhancement of postpartum cow health and calf performance through maternal‒offspring interactions: effects on the immunity, antioxidants, and bacterial flora induced by Guiqi Yimu Powder. | Anim Microbiome | 2026 | https://conductscience.org/library/papers/42436552 | PubMed |
| 42409802 | Intratumoral microbiota in tumorigenesis: A double-edged sword. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/42409802 | PubMed |
| 42356326 | Integrated Metabolomic and Microbiome Profiling Reveals Divergent Effects of No- and High-Fat Coffee in Mice. | Nutrients | 2026 | https://conductscience.org/library/papers/42356326 | PubMed |
| 42326439 | Artificial Sweeteners and Autoimmune Diseases: Insights From Integrative Bioinformatics and Mendelian Randomization. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42326439 | PubMed |
| 42274808 | Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42274808 | PubMed |
| 42273671 | Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence. | Front Immunol | 2026 | https://conductscience.org/library/papers/42273671 | PubMed |
| 42226670 | Synbiotic Supplementation With Heyndrickxia coagulans TBC169 Improves Chronic Constipation in Middle-Aged and Elderly. | Biotechnol J | 2026 | https://conductscience.org/library/papers/42226670 | PubMed |
| 42196983 | Travel-Induced Circadian and Microbiota Disturbances: Implications for Athlete Health and Performance: A Narrative Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42196983 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36557635
GET https://conductscience.org/api/papers/v1/36557635/references?page=2